PT1564293E - Expressão génica de proteínas de filamento neural e detecção de doença de alzheimer - Google Patents
Expressão génica de proteínas de filamento neural e detecção de doença de alzheimer Download PDFInfo
- Publication number
- PT1564293E PT1564293E PT04076254T PT04076254T PT1564293E PT 1564293 E PT1564293 E PT 1564293E PT 04076254 T PT04076254 T PT 04076254T PT 04076254 T PT04076254 T PT 04076254T PT 1564293 E PT1564293 E PT 1564293E
- Authority
- PT
- Portugal
- Prior art keywords
- neural thread
- alzheimer
- disease
- detection
- gene expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/474—Pancreatic thread protein; Reg protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5055993A | 1993-04-20 | 1993-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1564293E true PT1564293E (pt) | 2008-12-02 |
Family
ID=21965952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04076254T PT1564293E (pt) | 1993-04-20 | 1994-04-20 | Expressão génica de proteínas de filamento neural e detecção de doença de alzheimer |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1564293B9 (pt) |
| JP (2) | JP3513859B2 (pt) |
| KR (1) | KR100392244B1 (pt) |
| AT (2) | ATE312348T1 (pt) |
| CA (1) | CA2161097A1 (pt) |
| DE (2) | DE69434844T2 (pt) |
| DK (2) | DK1564293T3 (pt) |
| ES (2) | ES2255054T3 (pt) |
| NZ (1) | NZ266072A (pt) |
| PT (1) | PT1564293E (pt) |
| WO (1) | WO1994023756A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
| US5936078A (en) * | 1995-12-12 | 1999-08-10 | Kyowa Hakko Kogyo Co., Ltd. | DNA and protein for the diagnosis and treatment of Alzheimer's disease |
| EP0816492A1 (en) * | 1995-12-12 | 1998-01-07 | Kyowa Hakko Kogyo Co., Ltd. | Novel dnas, novel polypeptides and novel antibodies |
| EP0975651A4 (en) | 1997-02-26 | 2005-03-09 | Gen Hospital Corp | TRANSGENIC ANIMALS AND CELL LINES FOR THE SCREENING OF MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE |
| US7226730B1 (en) | 1997-02-26 | 2007-06-05 | The General Hospital Corporation | Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease |
| WO1998039967A1 (en) | 1997-03-12 | 1998-09-17 | The General Hospital Corporation | A method for treating or preventing alzheimer's disease |
| ATE300951T1 (de) | 2001-05-16 | 2005-08-15 | Nymox Corp | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
| EP1541166B1 (en) * | 2001-05-16 | 2007-12-19 | Nymox Corporation | Preventing cell death using segments of neural thread proteins |
| US6770797B2 (en) | 2001-06-01 | 2004-08-03 | Rhode Island Hospital | Non-Transgenic nonhuman model for Alzheimer's Disease using a AD7c-NTP nucleic acid |
| US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| EP1714979A3 (en) * | 2001-11-16 | 2007-04-25 | Nymox Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| SI1994152T1 (sl) | 2006-02-28 | 2013-05-31 | Nymox Corporation | Peptidi uäśinkoviti pri zdravljenju tumorjev in ostalih stanj, ki zahtevajo odstranitev ali uniäśenje celic |
| US20080027005A1 (en) * | 2006-07-31 | 2008-01-31 | Paul Averback | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
| WO2023217890A1 (en) * | 2022-05-10 | 2023-11-16 | F. Hoffmann-La Roche Ag | Antisense oligonucleotides targeting cfp-elk1 intergene region |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2094733T3 (es) * | 1988-12-21 | 1997-02-01 | Gen Hospital Corp | Deteccion de enfermedades o disfunciones neurologicas. |
-
1994
- 1994-04-20 PT PT04076254T patent/PT1564293E/pt unknown
- 1994-04-20 DK DK04076254T patent/DK1564293T3/da active
- 1994-04-20 ES ES94915396T patent/ES2255054T3/es not_active Expired - Lifetime
- 1994-04-20 DE DE69434844T patent/DE69434844T2/de not_active Expired - Fee Related
- 1994-04-20 ES ES04076254T patent/ES2312913T3/es not_active Expired - Lifetime
- 1994-04-20 AT AT94915396T patent/ATE312348T1/de not_active IP Right Cessation
- 1994-04-20 EP EP04076254A patent/EP1564293B9/en not_active Expired - Lifetime
- 1994-04-20 AT AT04076254T patent/ATE406444T1/de not_active IP Right Cessation
- 1994-04-20 DE DE69435136T patent/DE69435136D1/de not_active Expired - Fee Related
- 1994-04-20 EP EP94915396A patent/EP0697893B1/en not_active Expired - Lifetime
- 1994-04-20 WO PCT/US1994/004321 patent/WO1994023756A1/en active IP Right Grant
- 1994-04-20 CA CA002161097A patent/CA2161097A1/en not_active Abandoned
- 1994-04-20 NZ NZ266072A patent/NZ266072A/en not_active IP Right Cessation
- 1994-04-20 KR KR1019950704656A patent/KR100392244B1/ko not_active IP Right Cessation
- 1994-04-20 JP JP52355694A patent/JP3513859B2/ja not_active Expired - Fee Related
- 1994-04-20 DK DK94915396T patent/DK0697893T3/da active
-
2003
- 2003-10-01 JP JP2003343063A patent/JP2004097227A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2161097A1 (en) | 1994-10-27 |
| EP0697893A1 (en) | 1996-02-28 |
| AU6666994A (en) | 1994-11-08 |
| EP1564293B1 (en) | 2008-08-27 |
| ES2312913T3 (es) | 2009-03-01 |
| WO1994023756A1 (en) | 1994-10-27 |
| AU674581B2 (en) | 1997-01-02 |
| EP0697893A4 (en) | 1996-12-18 |
| NZ266072A (en) | 1997-07-27 |
| EP0697893B1 (en) | 2005-12-07 |
| DE69434844T2 (de) | 2006-12-14 |
| KR100392244B1 (ko) | 2003-11-28 |
| ATE406444T1 (de) | 2008-09-15 |
| DE69434844D1 (de) | 2006-10-19 |
| EP1564293B9 (en) | 2009-08-19 |
| DK0697893T3 (da) | 2006-02-20 |
| JP2004097227A (ja) | 2004-04-02 |
| JP3513859B2 (ja) | 2004-03-31 |
| DK1564293T3 (da) | 2009-01-12 |
| ES2255054T3 (es) | 2006-06-16 |
| DE69435136D1 (de) | 2008-10-09 |
| ATE312348T1 (de) | 2005-12-15 |
| EP1564293A1 (en) | 2005-08-17 |
| JPH08509808A (ja) | 1996-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1564293E (pt) | Expressão génica de proteínas de filamento neural e detecção de doença de alzheimer | |
| DE69735375D1 (de) | Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung | |
| EP0442961A4 (en) | Hybrid procoagulant proteins | |
| DK0939804T4 (da) | Neutrokin-alpha | |
| GR3030811T3 (en) | Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof | |
| EP1439230A3 (en) | Human transmembrane protein TMP-2 gene | |
| ATE365744T1 (de) | Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen | |
| NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
| DE69430818D1 (de) | Pns-dns-pns-chimäre makromoleküle | |
| SE8106641L (sv) | Hybrida humanleukocytinterferoner | |
| WO1998007850A3 (en) | Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans | |
| DE3684295D1 (de) | Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose. | |
| KR970705635A (ko) | 사람 케모킨 베타-9(Human chemokine beta-9) | |
| NO177863C (no) | Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer | |
| CA2344590A1 (en) | Treatment of inflammatory disease | |
| EP0837130A3 (en) | M protein analogue from Streptococcus pneumoniae | |
| WO1997035976A3 (en) | Epidermal differentiation factor | |
| KR860006484A (ko) | 단백질 또는 당단백질의 제조방법 | |
| CA2251262A1 (en) | Nucleic acid encoding a nervous tissue sodium channel | |
| AU5315790A (en) | Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes | |
| WO1998029438A3 (en) | Cortistatin polypeptides | |
| ATE300554T1 (de) | Bindegewebe-wachstumsfaktor 3. | |
| NO962596L (no) | Nytt tumorsupressorgen | |
| WO1996027015A3 (en) | A novel gene for a protein kinase associated with drug resistance | |
| MX9801603A (es) | Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria. |